SPR Therapeutics LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SPR Therapeutics LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10329
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation products. The company develops therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It offers percutaneous peripheral nerve stimulation system for interventional pain management. SPR Therapeutics’ product is used to treat chronic shoulder pain, chronic back pain, chronic post-amputation pain, post-op ankle arthroplasty, acute and chronic peripheral neuropathic pain, shoulder arthroplasty, and others. The company also develops MicroLead, a thread like flexible coiled lead designed to implant in proximity to the targeted peripheral nerve. SPR Therapeutics is headquartered in Cleveland, Ohio, the US.

SPR Therapeutics LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SPR Therapeutics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SPR Therapeutics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SPR Therapeutics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SPR Therapeutics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SPR Therapeutics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SPR Therapeutics LLC, Medical Equipment, Deal Details 10
Venture Financing 10
SPR Therapeutics Raises USD25 Million in Series C Financing 10
SPR Therapeutics Raises USD15 Million in Venture Financing 11
SPR Therapeutics Raises USD0.5 Million in Venture Financing 12
SPR Therapeutics Raises USD0.6 Million in Venture Financing 13
SPR Therapeutics To Raise US$3.8 Million In Venture Financing 14
SPR Therapeutics Raises US$5 Million In Series A Financing 15
SPR Therapeutics Raises Additional US$1.2 Million In Series A Venture Financing 16
SPR Therapeutics LLC – Key Competitors 17
SPR Therapeutics LLC – Key Employees 18
SPR Therapeutics LLC – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Sep 07, 2017: SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development 20
Mar 21, 2017: SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SPR Therapeutics LLC, Medical Equipment, Key Facts 2
SPR Therapeutics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SPR Therapeutics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SPR Therapeutics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SPR Therapeutics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SPR Therapeutics LLC, Deals By Market, 2012 to YTD 2018 8
SPR Therapeutics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SPR Therapeutics Raises USD25 Million in Series C Financing 10
SPR Therapeutics Raises USD15 Million in Venture Financing 11
SPR Therapeutics Raises USD0.5 Million in Venture Financing 12
SPR Therapeutics Raises USD0.6 Million in Venture Financing 13
SPR Therapeutics To Raise US$3.8 Million In Venture Financing 14
SPR Therapeutics Raises US$5 Million In Series A Financing 15
SPR Therapeutics Raises Additional US$1.2 Million In Series A Venture Financing 16
SPR Therapeutics LLC, Key Competitors 17
SPR Therapeutics LLC, Key Employees 18

List of Figures
SPR Therapeutics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SPR Therapeutics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SPR Therapeutics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SPR Therapeutics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SPR Therapeutics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SPR Therapeutics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SPR Therapeutics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SPR Therapeutics LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SPR Therapeutics LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ebiquity plc (EBQ):企業の財務・戦略的SWOT分析
    Summary Ebiquity plc (Ebiquity) is a marketing and media consultancy service provider. The company’s services include marketing performance optimization services, media value measurement and market intelligence. Its business areas comprise data analytics and advanced analytics. Ebiquity’s data analy …
  • BEML Ltd:企業の戦略・SWOT・財務分析
    BEML Ltd - Strategy, SWOT and Corporate Finance Report Summary BEML Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Genuine Parts Company:企業の戦略・SWOT・財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Air China Limited:企業の戦略・SWOT・財務情報
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Natural Alternatives International Inc (NAII):企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. The company manufactures and distributes the only patented beta-alanine supplement on the market. It offers services such as science-based product formulation, raw material ac …
  • Encore Wire Corporation:企業の戦略・SWOT・財務情報
    Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report Summary Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sun Pharmaceutical Industries Ltd (SUNPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psych …
  • Innospec Inc (IOSP):企業の財務・戦略的SWOT分析
    Innospec Inc (IOSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Teollisuuden Voima Oyj:企業の戦略的SWOT分析
    Teollisuuden Voima Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Rockwell Medical Inc (RMTI)-製薬・医療分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • Calytrix Technologies Pty Ltd.:企業の戦略・SWOT・財務情報
    Calytrix Technologies Pty Ltd. - Strategy, SWOT and Corporate Finance Report Summary Calytrix Technologies Pty Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Molecular Partners AG (MOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • New York Power Authority:発電所・企業SWOT分析
    New York Power Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Power Assets Holdings Ltd (6):電力:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Lonestar Resources US, Inc. (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Twoxar Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Twoxar Inc (Twoxar) is an artificial intelligence-driven drug discovery company that develops novel drug candidates. The company’s drug discovery technology platform evaluates public and proprietary datasets to identify high probability drug-disease matches based on orders of magnitude. Its …
  • Premier Foods plc (PFD):企業の財務・戦略的SWOT分析
    Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) operates as a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆